Impact of SGLT2 inhibitor dapagliflozin on myocardial protein profile in rats with long-standing Type 1 diabetes mellitus

1 September 2024 (15:00 - 15:50)
Organised by: Logo
Congress Presentation Part of: Diabetes, obesity, and the heart Antidiabetic Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by